Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial. |
|---|---|
| Authors: | Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, U.K. melanie.davies@uhl-tr.nhs.uk., Bain SC; Institute of Life Science, Swansea University, Swansea, U.K., Atkin SL; Qatar Foundation, Weill Cornell Medical College, Doha, Qatar., Rossing P; Steno Diabetes Center, Gentofte, Denmark., Scott D; Clinical Research Development Associates, Rosedale, NY., Shamkhalova MS; Department of Diabetic Nephropathy, Endocrinology Research Centre, Moscow, Russia., Bosch-Traberg H; Novo Nordisk A/S, Søborg, Denmark., Syrén A; Novo Nordisk A/S, Søborg, Denmark., Umpierrez GE; Division of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, GA. |
| Source: | Diabetes care [Diabetes Care] 2016 Feb; Vol. 39 (2), pp. 222-30. Date of Electronic Publication: 2015 Dec 17. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1935-5548 |
|---|---|
| DOI: | 10.2337/dc14-2883 |
